Related references
Note: Only part of the references are listed.Macrophages expedite cell proliferation of prostate intraepithelial neoplasia through their downstream target ERK
Mikalah U. Thomas et al.
FEBS JOURNAL (2021)
Causes of Death Among Patients With Metastatic Prostate Cancer in the US From 2000 to 2016
Ahmed O. Elmehrath et al.
JAMA NETWORK OPEN (2021)
The role of JNK in prostate cancer progression and therapeutic strategies
Ruiyuan Xu et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Role of Alternatively Spliced Messenger RNA (mRNA) Isoforms of the Insulin-Like Growth Factor 1 (IGF1) in Selected Human Tumors
Aldona Kasprzak et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Prostate Cancer Incidence and Survival, by Stage and Race/Ethnicity — United States, 2001–2017
David A. Siegel et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Randomized Phase II Study Evaluating Akt Blockade with Ipatasertib, in Combination with Abiraterone, in Patients with Metastatic Prostate Cancer with and without PTEN Loss
Johann S. de Bono et al.
CLINICAL CANCER RESEARCH (2019)
M2 macrophages and regulatory T cells in lethal prostate cancer
Ann Erlandsson et al.
PROSTATE (2019)
Macrophage Cytokines Enhance Cell Proliferation of Normal Prostate Epithelial Cells through Activation of ERK and Akt
Tu Dang et al.
SCIENTIFIC REPORTS (2018)
CD38 Is Robustly Induced in Human Macrophages and Monocytes in Inflammatory Conditions
Stephanie A. Amici et al.
FRONTIERS IN IMMUNOLOGY (2018)
Multifaceted Roles for Macrophages in Prostate Cancer Skeletal Metastasis
Chen Hao Lo et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
ProCAID: a phase I clinical trial to combine the AKT inhibitor AZD5363 with docetaxel and prednisolone chemotherapy for metastatic castration resistant prostate cancer
Simon J. Crabb et al.
INVESTIGATIONAL NEW DRUGS (2017)
Improving Cancer Chemoradiotherapy Treatment by Dual Controlled Release of Wortmannin and Docetaxel in Polymeric Nanoparticles
Kin Man Au et al.
ACS NANO (2015)
Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms
Tamas Roszer
MEDIATORS OF INFLAMMATION (2015)
Secreted Factors from Colorectal and Prostate Cancer Cells Skew the Immune Response in Opposite Directions
Marie Lundholm et al.
SCIENTIFIC REPORTS (2015)
Novel Markers to Delineate Murine M1 and M2 Macrophages
Kyle A. Jablonski et al.
PLOS ONE (2015)
Prognostic significance of osteopontin expression in non-small-cell lung cancer: A meta-analysis
Xue-Lin Zou et al.
MOLECULAR AND CLINICAL ONCOLOGY (2015)
Recent Progress in the Design, Study, and Development of c-Jun N-Terminal Kinase Inhibitors as Anticancer Agents
Abdellah Messoussi et al.
CHEMISTRY & BIOLOGY (2014)
The Role of M1 and M2 Macrophages in Prostate Cancer in relation to Extracapsular Tumor Extension and Biochemical Recurrence after Radical Prostatectomy
M. Lanciotti et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Macrophage cytokines: involvement in immunity and infectious diseases
Guillermo Arango Duque et al.
FRONTIERS IN IMMUNOLOGY (2014)
Tumor-Associated Macrophages as Major Players in the Tumor Microenvironment
Theerawut Chanmee et al.
CANCERS (2014)
Prostate cancer and inflammation: the evidence
Karen S. Sfanos et al.
HISTOPATHOLOGY (2012)
Revival of the abandoned therapeutic wortmannin by nanoparticle drug delivery
Shrirang Karve et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Differential macrophage programming in the tumor microenvironment
Brian Ruffell et al.
TRENDS IN IMMUNOLOGY (2012)
Infiltration of tumour-associated macrophages in prostate biopsy specimens is predictive of disease progression after hormonal therapy for prostate cancer
Norio Nonomura et al.
BJU INTERNATIONAL (2011)
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
Subhra K. Biswas et al.
NATURE IMMUNOLOGY (2010)
Macrophage polarization in tumour progression
Antonio Sica et al.
SEMINARS IN CANCER BIOLOGY (2008)
Prostate cancer specific integrin αvβ3 modulates bone metastatic growth and tissue remodeling
N. P. McCabe et al.
ONCOGENE (2007)
The role of osteopontin in tumor progression and metastasis in breast cancer
Ligia R. Rodrigues et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Prognostic significance of osteopontin expression in human prostate cancer
SS Forootan et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Increased expression of osteopontin contributes to the progression of prostate cancer
AC Khodavirdi et al.
CANCER RESEARCH (2006)
Distinct structural requirements for binding of the integrins αvβ6, αvβ3, αvβ5, α5β1 and α9β1 to osteopontin
Y Yokosaki et al.
MATRIX BIOLOGY (2005)
Osteopontin induces AP-1-mediated secretion of urokinase-type plasminogen activator through c-Src-dependent epidermal growth factor receptor transactivation in breast cancer cells
R Das et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Role of osteopontin in tumour progression
SR Rittling et al.
BRITISH JOURNAL OF CANCER (2004)
Targeting the PI3K-Akt pathway in human cancer: Rationale and promise
J Luo et al.
CANCER CELL (2003)
Osteopontin induces nuclear factor κB-mediated promatrix metalloproteinase-2 activation through IκBα/IKK signaling pathways, and curcumin (diferulolylmethane) down-regulates these pathways
S Philip et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Mechanisms of staurosporine induced apoptosis in a human corneal endothelial cell line
G Thuret et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2003)
Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy
F Chang et al.
LEUKEMIA (2003)
Development of PIN and prostate adenocarcinoma cell lines: A model system for multistage tumor progression
MA Shibata et al.
NEOPLASIA (2002)
Structural elements of the osteopontin SVVYGLR motif important for the interaction with α4 integrins
PM Green et al.
FEBS LETTERS (2001)
Staurosporine induces apoptosis through both caspase-dependent and caspase-independent mechanisms
CA Belmokhtar et al.
ONCOGENE (2001)
Silencing of CD44 expression in prostate cancer by hypermethylation of the CD44 promoter region
NS Verkaik et al.
LABORATORY INVESTIGATION (2000)
A regulated interaction between α5β1 integrin and osteopontin
ST Barry et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Share Paper
